News

NurExone expects to initiate a Phase 1/2a clinical trial in 2026 (" 2026 SCI Trial ”) marking a major milestone in the advancement of regenerative therapies for central nervous system injuries.
In November 2024, Florida Department of Education put out a 35-page document of books that were removed from schools, ...
President Trump issued an executive order directed at the higher-education accreditation process. Trump began the order by ...
After a lengthy debate the council backed the mayor in his determination to rid the city of all dogs on which the owners ...
The Champions League final on Saturday will be an especially busy one for Nasser Al-Khelaïfi, perhaps the most multi-tasked ...
W elcome to SportsLine on Friday, May 30. The most anticipated regular-season series this MLB campaign begins tonight in Los ...
Stevens has plenty of unfinished business ahead on the soccer pitch, but there’s certainly not a whole lot more the First Flight High School senior could have done throughout her prep ...
The greater Milwaukee area earned seven top seeds across the four WIAA baseball divisions. Here is a look at their playoff paths.
While ADHD and autism are both neurodevelopmental disorders, there are many key differences, including distinct symptoms, ...
NFL Commissioner Roger Goodell seeks to limit cap creativity in the next collective bargaining agreement. Here's how the ...
The Minnesota Vikings signed general manager Kwesi Adofo-Mensah to a multi-year contract extension, the team announced Friday ...